Home » Authors » Peter O'Donnell

Articles by Peter O'Donnell

EU Getting Tougher On States Not Complying With Biotech Rules

July 30, 2003

By Peter O'Donnell

EU Getting Tougher On States Not Complying With Biotech Rules

July 30, 2003

By Peter O'Donnell

EU Planning Guidelines On Embryonic Stem Cell Research

July 16, 2003

By Peter O'Donnell

EU Planning Guidelines On Embryonic Stem Cell Research

July 16, 2003

By Peter O'Donnell

Tough New GMO Labeling Rules Could End Approval Moratorium

July 9, 2003

By Peter O'Donnell

Tough New GMO Labeling Rules Could End Approval Moratorium

July 9, 2003

By Peter O'Donnell

G10 Paper Calls For Changes, Balance In EU Debate On Drugs

July 2, 2003

By Peter O'Donnell

G10 Paper Calls For Changes, Balance In EU Debate On Drugs

July 2, 2003

By Peter O'Donnell

European Firms Seek Incentives; EuropaBio Wants EU Stock Market

June 25, 2003

By Peter O'Donnell

European Firms Seek Incentives; EuropaBio Wants EU Stock Market

June 25, 2003

By Peter O'Donnell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 27, 2024.
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
Bridgebio, with FDA approval, faces Pfizer in ATTR
BioWorld
With the U.S. FDA approval of Attruby (acoramidis) for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), Bridgebio Pharma Inc. is taking on an industry...
Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection
BioWorld Asia
Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.